Advaxis Inc. | Balance Sheet

Fiscal year is November-October. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
20,552.10
17,606.90
112,156.20
152,087.50
70,885.10
45,118
Total Accounts Receivable
-
1,731.30
1,754.60
2,630.00
4,452.70
-
Other Current Assets
39.40
191.20
354.00
866.30
2,918.60
3,275
Total Current Assets
20,591.50
19,529.30
114,264.80
155,583.80
78,256.40
48,393
Net Property, Plant & Equipment
80.40
77.40
1,087.20
4,389.10
7,111.10
6,684
Intangible Assets
2,528.60
2,767.90
3,355.00
4,329.10
4,856.80
4,838
Other Assets
385.50
1,003.20
898.60
4,742.10
3,417.50
2,352
Total Assets
23,585.90
23,377.80
119,605.70
169,044.10
93,641.80
62,267
ST Debt & Current Portion LT Debt
226.00
62.90
29.50
-
-
Accounts Payable
3,841.80
1,411.10
-
1,720.40
5,121.40
Other Current Liabilities
869.30
1,241.80
3,888.10
25,986.00
15,742.90
Total Current Liabilities
4,937.00
2,715.70
3,917.60
27,706.40
20,864.30
Other Liabilities
646.70
32.10
89.20
22,035.50
18,517.30
Total Liabilities
5,583.80
2,747.80
4,006.80
49,741.90
39,381.60
Common Equity (Total)
18,002.10
20,630.00
115,598.90
119,302.20
54,260.20
Total Shareholders' Equity
18,002.10
20,630.00
115,598.90
119,302.20
54,260.20
Total Equity
18,002.10
20,630.00
115,598.90
119,302.20
54,260.20
Liabilities & Shareholders' Equity
23,585.90
23,377.80
119,605.70
169,044.10
93,641.80

About Advaxis

View Profile
Address
305 College Road East
Princeton New Jersey 08540
United States
Employees -
Website http://www.advaxis.com
Updated 07/08/2019
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy.